Caroverine

卡罗维林

Report date: 2022/08/17 14:43:14
NME

Base Information

Drug NameCaroverine
Drug Alias NamecaroverinacaroverinumSpasmiumTinnex
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated calcium channel blockersGlutamate [NMDA] receptor antagonists
TargetsVoltage-gated calcium channelGlutamate [NMDA] receptor
Therapy Area/IndicationsPainSpasmTinnitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustriaMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaDiscontinued
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsPainSpasm
Inactive IndicationsTinnitus

Other Information

ATC CodeA03AX11
Related LinksWikipediaKEGG